Abstract
Intracerebral hemorrhage (ICH) (10–30 % of first-ever strokes) refers to bleeding within the brain parenchyma.
It may be spontaneous or due to arteriovenous malformations (AVM), aneurisms causing subarachnoid hemorrhage (SAH), cavernous malformation (CM), intracranial dural arteriovenous fistulas (DAVFs), and Moyamoya disease (MMD).
Older age, hypertension, alcohol intake, and cerebral amyloid angiopathy are all risk factors for spontaneous intracerebral bleeding.
Prognosis of ICH varies depending on:AVM: 7.4 % after microsurgery, 5.1 % after stereotactic radiosurgery, and 6.6 % after embolization.SAH and DAVFs: survivors are 65–75 % with 1/3 of survivors with permanent morbidity.Asymptomatic MMD: overall stroke risk is 3.2 %/year. Symptomatic MMD: the 5-year risk of recurrent ipsilateral stroke is 65 % if medically treated, 17 % if submitted to surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Broderick J, Connolly S, Feldmann E, et al, and the American Heart Association, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001–23.
Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355–69.
van Asch CJ, Luitse MJA, Rinkel GJE, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–76.
Ariesen MJ, Claus SP, Rinkel GJE, et al. Risk factors for intracerebral hemorrhage in the general population. Stroke. 2003;34(8):2060–5.
Matsukawa H, Shinoda M, Fujii M, et al. Factors associated with lobar vs. nonlobar intracerebral hemorrhage. Acta Neurol Scand. 2011. http://dx.doi.org/10.1111/j.1600-0404.2011.01615.x.
Wieberdink RG, Poels MMF, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31(12):2982–9.
Martin-Schild S, Albright KC, Hallevi H, et al. Intracerebral hemorrhage in cocaine users. Stroke. 2010;41(4):680–4.
Flaherty ML. Anticoagulant-associated intracerebral hemorrhage. Semin Neurol. 2010;30(5):565–72.
Biffi A, Sonni A, Anderson CD, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68(6):934–43.
Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29.
Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage—part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006;22(4):294–316.
Zia E, Engstrom G, Svensson PJ, et al. Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage. Stroke. 2009;40:3567–73.
Balami JD, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol. 2012;11:101–18.
Hemphill 3rd JC, Bonovich DC, Besmertis L, et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.
Hemphill JC, Farrant M, Neill TA. Prospective validation of the ICH Score for 12-month functional outcome. Neurology. 2009;73:1088–94.
Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39:2304–9.
Witsch J, Neugebauer H, Zweckberger K, Jüttler E. Primary cerebellar haemorrhage: complications, treatment and outcome. Clin Neurol Neurosurg. 2013;115(7):863–9.
Al-Shahi R, Fang JS, Lewis SC, Warlow CP. Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry. 2002;73(5):547–51.
Stapf C, Labovitz DL, Sciacca RR, et al. Incidence of adult brain arteriovenous malformation hemorrhage in a prospective population-based stroke survey. Cerebrovasc Dis. 2002;13(1):43–6.
Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.
Hernesniemi JA, Dashti R, Juvela S, et al. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008;63(5):823–9.
van Beijnum J, van der Worp HB, Buis RD, et al. Treatment of brain arteriovenous malformations. A systematic review and meta-analysis. JAMA. 2011;306(18):2011–9.
Mohr JP, Parides MK, Stapf C, et al. International ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomized trial. Lancet. 2014;383(9917):614–21. doi:10.1016/S0140-6736(13)62302-8. Epub 2013 Nov 20.
Caceres JA, Goldstein JN. Intracranial hemorrhage. Emerg Med Clin North Am. 2012;30:771–94.
Vlak MH, Algra A, Brandenburg R, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10(7):626–36.
Risselada R, Lingsma HF, Bauer-Mehren A, et al. Prediction of 60 day case fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT). Eur J Epidemiol. 2010;25(4):261–6.
Rosengart AJ, Schultheiss KE, Tolentino J, et al. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(8):2315–21.
Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34:1163–9.
Li D, Yang Y, Hao SY, Wang L, et al. Hemorrhage risk, surgical management, and functional outcome of brainstem cavernous malformations. J Neurosurg. 2013;119(4):996–1008.
Batra S, Lin D, Recinos P, et al. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol. 2009;5:659–70.
Josephson CB, Salman RAS. Hemorrhage: new and recurrent. In: Cavernous malformations of the nervous system. ed. Daniele Rigamonti. Cambridge: Cambridge University Press; 2011.
Kupersmith M, Kalish H, Epstein F, et al. Natural history of brainstem cavernous malformations. Neurosurgery. 2001;48:47–53; discussion 53–44.
Labauge P, Brunereau L, Laberge S, et al. Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations. Neurology. 2001;57:1825–8.
Luciani A, Houdart E, Mounayer C, et al. Spontaneous closure of dural arteriovenous fistulas: report of three cases and review of the literature. AJNR Am J Neuroradiol. 2001;22:992–6.
Daniels DJ, Vellimana AK, Zipfel GJ, Lanzino G. Intracranial hemorrhage from dural arteriovenous fistulas: clinical features and outcome. Neurosurg Focus. 2013;34(5):E15.
Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39:42–7.
Pandey P, Steinberg GK. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011;42:3304–10.
Jang DK, Lee KS, Rha HK, Huh PW, et al. Clinical and angiographic features and stroke types in adult moyamoya disease. AJNR Am J Neuroradiol. 2014;35(6):1124–31.
Liu W, Zhu S, Wang X, et al. Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult Moyamoya disease. J Clin Neurosci. 2011;18:374–8.
Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007;38:1430–5.
Hallemeier CL, Rich KM, Grubb Jr RL, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490–6.
Miyamoto S, Yoshimoto T, Hashimoto N, et al. JAM Trial Investigators. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014;45(5):1415–21.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
Caputi, L., Bersano, A., Parati, E.A. (2015). Vascular Diseases: Cerebral Hemorrhage. In: Sghirlanzoni, A., Lauria, G., Chiapparini, L. (eds) Prognosis of Neurological Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-5755-5_2
Download citation
DOI: https://doi.org/10.1007/978-88-470-5755-5_2
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5754-8
Online ISBN: 978-88-470-5755-5
eBook Packages: MedicineMedicine (R0)